echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The Central Commission for Discipline Inspection: 290 pharmaceutical companies whose sales expenses were investigated

    The Central Commission for Discipline Inspection: 290 pharmaceutical companies whose sales expenses were investigated

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical News February 22 
     
    Retrieve the annual reports of 290 companies
     
    On February 19, the official website of the Central Commission for Discipline Inspection published an article "Eliminating the breeding ground for medical corruption".
    The article pointed out that the former party secretary and dean of a well-known tertiary hospital was investigated for illegally accepting property from others.
     
    After the review and investigation of the main body of work, the review and investigators did not directly "receive the soldiers".
    The task force spent more than a month to investigate the corruption in the city's medical system.
    Through many on-site visits to relevant units, the staff of the Municipal Commission for Discipline Inspection and Supervision conducted face-to-face conversations with all members of the hospital and cadres at important positions, forming a strong deterrent.
     
    The annual reports of more than 290 listed pharmaceutical companies across the country were retrieved, and sales expenses were analyzed and interpreted.
    Finally, many management loopholes and blind spots in supervision were dug out.
     
    The relevant person in charge of the Commission for Discipline Inspection and Supervision said that taking the review and investigation as an example, not only should we attach great importance to issues such as the harm to the interests of the people in the field of people’s livelihood, we must strictly investigate and deal with them quickly, but also we need to promote the reform of the "second half of the article" to the greatest extent possible Unearthing the warning education value of the case, promote the in-depth governance of related industries, and force the continuous improvement of work style and service quality.
     
    The Commission for Discipline Inspection and Supervision has explored the establishment of a "one case, five must" system.
    For every typical case, case notification, investigation and analysis, warning education, rectification and reconstruction system, and return visit supervision must be carried out.
     
      On January 28, according to the website of the State Supervision Commission of the Central Commission for Discipline Inspection, from 2011 to 2019, Hu Shuangfei used his position as the director of the anesthesiology department to provide assistance in the access, sales, and use of drugs from several pharmaceutical companies.
    Received more than 3.
    45 million yuan in drug rebates from multiple medical representatives.
     
      According to the official website of the Central Commission for Discipline Inspection, at the end of 2016, a medical representative found Hu Shuangfei and gave Hu Shuangfei 200,000 yuan in a lump sum.
    It was known as the "year-end thank you gift" given by the company to such "super VIP customers".
    In July 2020, Hu Shuangfei was sentenced to five and nine months imprisonment and fined 500,000 yuan by the Hangzhou Xiaoshan District People's Court for the crime of accepting bribes.
     
      Some product rebates have exceeded 40%
     
      At the end of 2020, according to the Health Times, a few days ago, Wang Mou, director of the Second Respiratory Department of the First Affiliated Hospital of Zhengzhou University, was reported by real name.
    The informant Ms.
    Yuan pointed out that Wang Mou has multiple violations of regulations and disciplines.
     
      The report wrote that Wang Mou, director of the Second Respiratory Department of the First Affiliated Hospital of Zheng University, and her husband had a number of violations of laws and disciplines, suspected of taking bribes, illegal lending, unidentified sources of huge amounts of property, buying stock funds with illegal income, tax evasion, and false lawsuits.
    , Collection of drug rebates, etc.
     
      The whistleblower pointed out that Wang used his power to collude with the salesman of the pharmaceutical manufacturer and accept bribes for a long time.
    He obtained huge wealth quickly by illegally accepting bribes, purchased a large amount of property, and illegally issued loans to many enterprises in the society and engaged in illegal operations.
    activity.
     
      The website of the Central Commission for Discipline Inspection has repeatedly published articles such as strictly investigating power and money transactions and cutting off the benefit chain of medical bribery.
    The content directly refers to the improper transactions between medical representatives and medical institutions.
     
      Among the corruption cases in the medical field disclosed since the beginning of this year, the rebate of medicines and consumables has been charged the most frequently, showing that the amount involved in the case remains high and the chain of corruption interests is interlocking.
     
      The person involved in the case explained that the criteria for finding drugs are one that is lacking in the hospital, and the other is that the scope of application is relatively large, such as respiratory medicine, neurology, and neurosurgery.
    "The larger the scope, the larger the sales and the higher the profit.
    ".
    Many drug dealers said that the rebate was as high as 40% of the retail price of the drug .
     
      A recent judgment published by China Judgment Documents website shows that the former director of the Department of Cardiovascular Medicine, a hospital in Suzhou, Jiangsu Province, used his position to provide support and assistance for the sales and use of medical consumables pharmnet.
    com.
    cn/agent_product/" target="_blank">represented by multiple companies , and received the actual person in charge of the above-mentioned company.
    Fan gave RMB 3.
    22 million.
     
      The relevant person in charge of the Price Recruitment Department of the National Medical Security Administration stated that according to the statistics of publicly available court judgments, more than half of the 100 compulsory drug companies in the country from 2016 to 2019 were found to have directly or indirectly given rebates.
    Among them, the frequency The highest enterprise involved more than 20 cases in three years, and the rebate amount in a single case exceeded 20 million yuan.
     
      At present, once pharmaceutical companies have untrustworthy behaviors, they will face written reminders, rely on centralized procurement platforms to prompt purchasers of risk information, restrict or suspend the listing of relevant drugs or medical consumables, restrict or suspend the purchase of relevant drugs or medical consumables, and disclose untrustworthy information If the number of provinces involved in untrustworthy behavior meets the prescribed conditions, such as disposal measures, the National Medical Insurance Bureau’s Medical Price and Bidding and Procurement Guidance Center will also initiate a nationwide joint disposal.
    Medical News February 22 
     
      Retrieve the annual reports of 290 companies
     
      On February 19, the official website of the Central Commission for Discipline Inspection published an article "Eliminating the breeding ground for medical corruption".
    The article pointed out that the former party secretary and dean of a well-known tertiary hospital was investigated for illegally accepting property from others.
     
      After the review and investigation of the main body of work, the review and investigators did not directly "receive the soldiers".
    The task force spent more than a month to investigate the corruption in the city's medical system.
    Through many on-site visits to relevant units, the staff of the Municipal Commission for Discipline Inspection and Supervision conducted face-to-face conversations with all members of the hospital and cadres at important positions, forming a strong deterrent.
     
      The annual reports of more than 290 listed pharmaceutical companies across the country were retrieved, and sales expenses were analyzed and interpreted.
    Finally, many management loopholes and blind spots in supervision were dug out.
     
      The relevant person in charge of the Commission for Discipline Inspection and Supervision said that taking the review and investigation as an example, not only should we attach great importance to issues such as the harm to the interests of the people in the field of people’s livelihood, we must strictly investigate and deal with them quickly, but also we need to promote the reform of the "second half of the article" to the greatest extent possible Unearthing the warning education value of the case, promote the in-depth governance of related industries, and force the continuous improvement of work style and service quality.
     
      The Commission for Discipline Inspection and Supervision has explored the establishment of a "one case, five must" system.
    For every typical case, case notification, investigation and analysis, warning education, rectification and reconstruction system, and return visit supervision must be carried out.
     
      On January 28, according to the website of the State Supervision Commission of the Central Commission for Discipline Inspection, from 2011 to 2019, Hu Shuangfei used his position as the director of the anesthesiology department to provide assistance in the access, sales, and use of drugs from several pharmaceutical companies.
    Received more than 3.
    45 million yuan in drug rebates from multiple medical representatives.
     
      According to the official website of the Central Commission for Discipline Inspection, at the end of 2016, a medical representative found Hu Shuangfei and gave Hu Shuangfei 200,000 yuan in a lump sum.
    It was known as the "year-end thank you gift" given by the company to such "super VIP customers".
    In July 2020, Hu Shuangfei was sentenced to five and nine months imprisonment and fined 500,000 yuan by the Hangzhou Xiaoshan District People's Court for the crime of accepting bribes.
     
      Some product rebates have exceeded 40%
     
      At the end of 2020, according to the Health Times, a few days ago, Wang Mou, director of the Second Respiratory Department of the First Affiliated Hospital of Zhengzhou University, was reported by real name.
    The informant Ms.
    Yuan pointed out that Wang Mou has multiple violations of regulations and disciplines.
     
      The report wrote that Wang Mou, director of the Second Respiratory Department of the First Affiliated Hospital of Zheng University, and her husband had a number of violations of laws and disciplines, suspected of taking bribes, illegal lending, unidentified sources of huge amounts of property, buying stock funds with illegal income, tax evasion, and false lawsuits.
    , Collection of drug rebates, etc.
     
      The whistleblower pointed out that Wang used his power to collude with the salesman of the pharmaceutical manufacturer and accept bribes for a long time.
    He obtained huge wealth quickly by illegally accepting bribes, purchased a large amount of property, and illegally issued loans to many enterprises in the society and engaged in illegal operations.
    activity.
     
      The website of the Central Commission for Discipline Inspection has repeatedly published articles such as strictly investigating power and money transactions and cutting off the benefit chain of medical bribery.
    The content directly refers to the improper transactions between medical representatives and medical institutions.
     
      Among the corruption cases in the medical field disclosed since the beginning of this year, the rebate of medicines and consumables has been charged the most frequently, showing that the amount involved in the case remains high and the chain of corruption interests is interlocking.
     
      The person involved in the case explained that the criteria for finding drugs are one that is lacking in the hospital, and the other is that the scope of application is relatively large, such as respiratory medicine, neurology, and neurosurgery.
    "The larger the scope, the larger the sales and the higher the profit.
    ".
    Many drug dealers said that the rebate was as high as 40% of the retail price of the drug .
     
      A recent judgment published by China Judgment Documents website shows that the former director of the Department of Cardiovascular Medicine, a hospital in Suzhou, Jiangsu Province, used his position to provide support and assistance for the sales and use of medical consumables pharmnet.
    com.
    cn/agent_product/" target="_blank">represented by multiple companies , and received the actual person in charge of the above-mentioned company.
    Fan gave RMB 3.
    22 million.
     
      The relevant person in charge of the Price Recruitment Department of the National Medical Security Administration stated that according to the statistics of publicly available court judgments, more than half of the 100 compulsory drug companies in the country from 2016 to 2019 were found to have directly or indirectly given rebates.
    Among them, the frequency The highest enterprise involved more than 20 cases in three years, and the rebate amount in a single case exceeded 20 million yuan.
     
      At present, once pharmaceutical companies have untrustworthy behaviors, they will face written reminders, rely on centralized procurement platforms to prompt purchasers of risk information, restrict or suspend the listing of relevant drugs or medical consumables, restrict or suspend the purchase of relevant drugs or medical consumables, and disclose untrustworthy information If the number of provinces involved in untrustworthy behavior meets the prescribed conditions, such as disposal measures, the National Medical Insurance Bureau’s Medical Price and Bidding and Procurement Guidance Center will also initiate a nationwide joint disposal.
    Medical News February 22 
     
      Retrieve the annual reports of 290 companies
      Retrieve the annual reports of 290 companies
     
      On February 19, the official website of the Central Commission for Discipline Inspection published an article "Eliminating the breeding ground for medical corruption".
    The article pointed out that the former party secretary and dean of a well-known tertiary hospital was investigated for illegally accepting property from others.
    Hospital hospital hospital
     
      After the review and investigation of the main body of work, the review and investigators did not directly "receive the soldiers".
    The task force spent more than a month to investigate the corruption in the city's medical system.
    Through many on-site visits to relevant units, the staff of the Municipal Commission for Discipline Inspection and Supervision conducted face-to-face conversations with all members of the hospital and cadres at important positions, forming a strong deterrent.
     
      The annual reports of more than 290 listed pharmaceutical companies across the country were retrieved, and sales expenses were analyzed and interpreted.
    Finally, many management loopholes and blind spots in supervision were dug out.
     
      The relevant person in charge of the Commission for Discipline Inspection and Supervision said that taking the review and investigation as an example, not only should we attach great importance to issues such as the harm to the interests of the people in the field of people’s livelihood, we must strictly investigate and deal with them quickly, but also we need to promote the reform of the "second half of the article" to the greatest extent possible Unearthing the warning education value of the case, promote the in-depth governance of related industries, and force the continuous improvement of work style and service quality.
     
      The Commission for Discipline Inspection and Supervision has explored the establishment of a "one case, five must" system.
    For every typical case, case notification, investigation and analysis, warning education, rectification and reconstruction system, and return visit supervision must be carried out.
     
      On January 28, according to the website of the State Supervision Commission of the Central Commission for Discipline Inspection, from 2011 to 2019, Hu Shuangfei used his position as the director of the anesthesiology department to provide assistance in the access, sales, and use of drugs from several pharmaceutical companies.
    Received more than 3.
    45 million yuan in drug rebates from multiple medical representatives.
     
      According to the official website of the Central Commission for Discipline Inspection, at the end of 2016, a medical representative found Hu Shuangfei and gave Hu Shuangfei 200,000 yuan in a lump sum.
    It was known as the "year-end thank you gift" given by the company to such "super VIP customers".
    In July 2020, Hu Shuangfei was sentenced to five and nine months imprisonment and fined 500,000 yuan by the Hangzhou Xiaoshan District People's Court for the crime of accepting bribes.
     
      Some product rebates have exceeded 40%
      Some product rebates have exceeded 40%
     
      At the end of 2020, according to the Health Times, a few days ago, Wang Mou, director of the Second Respiratory Department of the First Affiliated Hospital of Zhengzhou University, was reported by real name.
    The informant Ms.
    Yuan pointed out that Wang Mou has multiple violations of regulations and disciplines.
     
      The report wrote that Wang Mou, director of the Second Respiratory Department of the First Affiliated Hospital of Zheng University, and her husband had a number of violations of laws and disciplines, suspected of taking bribes, illegal lending, unidentified sources of huge amounts of property, buying stock funds with illegal income, tax evasion, and false lawsuits.
    , Collection of drug rebates, etc.
     
      The whistleblower pointed out that Wang used his power to collude with the salesman of the pharmaceutical manufacturer and accept bribes for a long time.
    He obtained huge wealth quickly by illegally accepting bribes, purchased a large amount of property, and illegally issued loans to many enterprises in the society and engaged in illegal operations.
    activity.
     
      The website of the Central Commission for Discipline Inspection has repeatedly published articles such as strictly investigating power and money transactions and cutting off the benefit chain of medical bribery.
    The content directly refers to the improper transactions between medical representatives and medical institutions.
     
      Among the corruption cases in the medical field disclosed since the beginning of this year, the rebate of medicines and consumables has been charged the most frequently, showing that the amount involved in the case remains high and the chain of corruption interests is interlocking.
     
      The person involved in the case explained that the criteria for finding drugs are one that is lacking in the hospital, and the other is that the scope of application is relatively large, such as respiratory medicine, neurology, and neurosurgery.
    "The larger the scope, the larger the sales and the higher the profit.
    ".
    Many drug dealers said that the rebate was as high as 40% of the retail price of the drug .
    Medicine, medicine, medicine
     
      A recent judgment published by China Judgment Documents website shows that the former director of the Department of Cardiovascular Medicine, a hospital in Suzhou, Jiangsu Province, used his position to provide support and assistance for the sales and use of medical consumables pharmnet.
    com.
    cn/agent_product/" target="_blank">represented by multiple companies , and received the actual person in charge of the above-mentioned company.
    Fan gave RMB 3.
    22 million.
    pharmnet.
    com.
    cn/agent_product/" target="_blank">Agentpharmnet.
    com.
    cn/agent_product/" target="_blank"> Agent Agent
     
      The relevant person in charge of the Price Recruitment Department of the National Medical Security Administration stated that according to the statistics of publicly available court judgments, more than half of the 100 compulsory drug companies in the country from 2016 to 2019 were found to have directly or indirectly given rebates.
    Among them, the frequency The highest enterprise involved more than 20 cases in three years, and the rebate amount in a single case exceeded 20 million yuan.
    Enterprise business enterprise
     
      At present, once pharmaceutical companies have untrustworthy behaviors, they will face written reminders, rely on centralized procurement platforms to prompt purchasers of risk information, restrict or suspend the listing of relevant drugs or medical consumables, restrict or suspend the purchase of relevant drugs or medical consumables, and disclose untrustworthy information If the number of provinces involved in untrustworthy behavior meets the prescribed conditions, such as disposal measures, the National Medical Insurance Bureau’s Medical Price and Bidding and Procurement Guidance Center will also initiate a nationwide joint disposal.
    Medicine Medicine Medicine
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.